GlycoNAVI Proteins

GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.

Source Last Updated
GlycoNAVI Proteins October 24, 2024
Displaying entries 36851 - 36900 of 39437 in total
PDB ID UniProt ID Title Descriptor
7RF8 Q8DJI1 RT XFEL structure of the two-flash state of Photosystem II (2F, S3-rich) at 2.09 Angstrom resolution
7RF8 Q8DHJ2 RT XFEL structure of the two-flash state of Photosystem II (2F, S3-rich) at 2.09 Angstrom resolution
7S0C P0DTC2 Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody N-612-017
7S0C 7S0C Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody N-612-017
7SOF P0DTC2 SARS-CoV-2 S NTD B.1.617.1 kappa variant S2X303 Local Refinement
7SOF 7SOF SARS-CoV-2 S NTD B.1.617.1 kappa variant S2X303 Local Refinement
7SXY P0DTC2 Cryo-EM structure of the SARS-CoV-2 D614G mutant spike protein ectodomain bound to human ACE2 ectodomain (focused refinement of RBD and ACE2)
7SXY Q9BYF1 Cryo-EM structure of the SARS-CoV-2 D614G mutant spike protein ectodomain bound to human ACE2 ectodomain (focused refinement of RBD and ACE2)
7SY1 P0DTC2 Cryo-EM structure of the SARS-CoV-2 D614G,N501Y mutant spike protein ectodomain bound to human ACE2 ectodomain (global refinement)
7SY1 Q9BYF1 Cryo-EM structure of the SARS-CoV-2 D614G,N501Y mutant spike protein ectodomain bound to human ACE2 ectodomain (global refinement)
7SY2 P0DTC2 Cryo-EM structure of the SARS-CoV-2 D614G,N501Y mutant spike protein ectodomain bound to human ACE2 ectodomain (focused refinement of RBD and ACE2)
7SY2 Q9BYF1 Cryo-EM structure of the SARS-CoV-2 D614G,N501Y mutant spike protein ectodomain bound to human ACE2 ectodomain (focused refinement of RBD and ACE2)
7T9K P0DTC2 Cryo-EM structure of SARS-CoV-2 Omicron spike protein in complex with human ACE2
7T9K Q9BYF1 Cryo-EM structure of SARS-CoV-2 Omicron spike protein in complex with human ACE2
7V7A P0DTC2 Cryo-EM structure of SARS-CoV-2 S-Gamma variant (P.1), two RBD-up conformation
7ACX Q8KHI4 H/L (SLPH/SLPL) complex from C. difficile (R7404 strain)
7ACX Q9AEM2 H/L (SLPH/SLPL) complex from C. difficile (R7404 strain)
7E9O P0DTC2 Cryo-EM structure of the SARS-CoV-2 S-6P in complex with 35B5 Fab(3 up RBDs, state2)
7E9O 7E9O Cryo-EM structure of the SARS-CoV-2 S-6P in complex with 35B5 Fab(3 up RBDs, state2)
7E9Q P0DTC2 Cryo-EM structure of the SARS-CoV-2 S-6P in complex with 35B5 Fab(1 out RBD, state3)
7E9Q 7E9Q Cryo-EM structure of the SARS-CoV-2 S-6P in complex with 35B5 Fab(1 out RBD, state3)
7LAW Q9UNG2 crystal structure of GITR complex with GITR-L
7LAW Q9Y5U5 crystal structure of GITR complex with GITR-L
7LX2 7LX2 Cryo-EM structure of ConSOSL.UFO.664 (ConS) in complex with bNAb PGT122
7LX3 7LX3 Cryo-EM structure of EDC-crosslinked ConSOSL.UFO.664 (ConS-EDC) in complex with bNAb PGT122
7LXM 7LXM Cryo-EM structure of ConM SOSIP.v7 (ConM) in complex with bNAb PGT122
7LXN 7LXN Cryo-EM structure of EDC-crosslinked ConM SOSIP.v7 (ConM-EDC) in complex with bNAb PGT122
7NYT P62694 Trichoderma reesei Cel7A E212Q mutant in complex with lactose.
7OC8 P62694 Trichoderma reesei Cel7A E212Q mutant in complex with pNPL
7Q1Z P0DTC2 Structure of formaldehyde cross-linked SARS-CoV-2 S glycoprotein
7QPU C1IPK2 Botulinum neurotoxin A5 cell binding domain in complex with GM1b oligosaccharide
7R0Z P0DTC2 Dissociated S1 domain of Alpha Variant SARS-CoV-2 Spike bound to ACE2 (Non-Uniform Refinement)
7R0Z Q9BYF1 Dissociated S1 domain of Alpha Variant SARS-CoV-2 Spike bound to ACE2 (Non-Uniform Refinement)
7R11 P0DTC2 Dissociated S1 domain of Beta Variant SARS-CoV-2 Spike bound to ACE2 (Non-Uniform Refinement)
7R11 Q9BYF1 Dissociated S1 domain of Beta Variant SARS-CoV-2 Spike bound to ACE2 (Non-Uniform Refinement)
7R12 P0DTC2 Dissociated S1 domain of Mink Variant SARS-CoV-2 Spike bound to ACE2 (Non-Uniform Refinement)
7R12 Q9BYF1 Dissociated S1 domain of Mink Variant SARS-CoV-2 Spike bound to ACE2 (Non-Uniform Refinement)
7R13 P0DTC2 Alpha Variant SARS-CoV-2 Spike in Closed conformation
7R14 P0DTC2 Alpha Variant SARS-CoV-2 Spike with 1 Erect RBD
7R16 P0DTC2 Beta Variant SARS-CoV-2 Spike with 1 Erect RBD
7R17 P0DTC2 Beta Variant SARS-CoV-2 Spike with 2 Erect RBDs
7R18 P0DTC2 Mink Variant SARS-CoV-2 Spike in Closed conformation
7R19 P0DTC2 Mink Variant SARS-CoV-2 Spike with 2 Erect RBDs
7R1B P0DTC2 Mink Variant SARS-CoV-2 Spike with 1 Erect RBD
7S5P P0DTC2 Crystal structure of SARS-CoV-2 B.1.351 variant receptor binding domain in complex with neutralizing antibody CS23
7S5P 7S5P Crystal structure of SARS-CoV-2 B.1.351 variant receptor binding domain in complex with neutralizing antibody CS23
7S5Q P0DTC2 Crystal structure of SARS-CoV-2 B.1.351 variant receptor binding domain in complex with neutralizing antibodies CS44 and COVA1-16
7S5Q 7S5Q Crystal structure of SARS-CoV-2 B.1.351 variant receptor binding domain in complex with neutralizing antibodies CS44 and COVA1-16
7S5R P0DTC2 Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibodies CV07-287 and COVA1-16
7S5R 7S5R Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibodies CV07-287 and COVA1-16

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024